AR071530A1 - Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk) - Google Patents
Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk)Info
- Publication number
- AR071530A1 AR071530A1 ARP090101562A ARP090101562A AR071530A1 AR 071530 A1 AR071530 A1 AR 071530A1 AR P090101562 A ARP090101562 A AR P090101562A AR P090101562 A ARP090101562 A AR P090101562A AR 071530 A1 AR071530 A1 AR 071530A1
- Authority
- AR
- Argentina
- Prior art keywords
- denotes
- het
- formula
- hal
- atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Abstract
La invencion se refiere a compuestos de la formula (1) en donde R1 denota H, A, OA, OH, Hal, NO2, COOA, COOH, CHO, COA, CONH2, CONHA, CONA2, CN, SO2A, SO2NH2, Ar o Het, R2 denota Ar o Het, B1 denota Ar-diílo o Het-diílo, B2 denota Ar o Het, Ar denota fenilo, naftilo, cada uno de los cuales no está sustituido o está mono-, di-, tri-, tetra- o pentasustituido con A, Hal, OA, OH, CHO, COA, NH2, NHA, NA2, NO2, COOA, COOH, CONH2, CONA, CONA2, SO2A, CN, C(=NH)NH2, C(=NH)NHOH y/o Het, Het denota un heterociclo insaturado o aromático mono- o bicíclico que tiene de 1 a 4 átomos de N, O y/o S, que puede estar mono-, di- o trisustituido con Hal, A, OA, OH, CHO, COA, COOH, COOA, CN, NO2, NH2, NHA, NA2, CONH2, CONHA y/o CONA2, A denota alquilo no ramificado o ramificado que tiene 1-10 átomos de C, en los que 1-7 átomos de H pueden estar reemplazados por OH, F, Cl y/o Br, o denota cicloalquilo que tiene 3-7 átomos de C, Hal denota F, Cl, Br o I, y sus derivados, sales, solvatos y estereoisomeros farmacéuticamente aceptables, incluyendo sus mezclas en todas las proporciones. Incluyendo sus composiciones farmacéuticas y su uso en el tratamiento y/o la prevencion de enfermedades y trastornos modulados por agonistas de AMP. La invencion también se refiere a intermediarios y a un método de preparacion de compuestos de la formula (1). Reivindicacion 12: Un compuesto de la formula (2) para preparar un compuesto de la formula 1 en donde R1, R2, B1 tienen los significados indicados en la reivindicacion 1, y X es un átomo de halogeno, y sus sales. Reivindicacion 13: Un compuesto de la formula (3) para preparar un compuesto de la formula 2 en donde R1, R2, B1 tienen los significados indicados en la reivindicacion 1, X es un átomo de halogeno, y ALK denota alquilo C1-6 y sus sales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08290423 | 2008-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR071530A1 true AR071530A1 (es) | 2010-06-23 |
Family
ID=40756916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090101562A AR071530A1 (es) | 2008-05-05 | 2009-04-30 | Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk) |
Country Status (27)
Country | Link |
---|---|
US (1) | US8604202B2 (es) |
EP (1) | EP2280952B1 (es) |
JP (1) | JP5536757B2 (es) |
KR (2) | KR20160038065A (es) |
CN (1) | CN102015676B (es) |
AR (1) | AR071530A1 (es) |
AU (1) | AU2009243811B2 (es) |
BR (1) | BRPI0910832B8 (es) |
CA (1) | CA2723429C (es) |
CO (1) | CO6331304A2 (es) |
CY (1) | CY1113112T1 (es) |
DK (1) | DK2280952T3 (es) |
EA (1) | EA020773B1 (es) |
EC (1) | ECSP10010654A (es) |
ES (1) | ES2388485T3 (es) |
HK (1) | HK1156313A1 (es) |
HR (1) | HRP20120549T1 (es) |
IL (1) | IL208988A (es) |
MX (1) | MX2010011916A (es) |
MY (1) | MY160357A (es) |
NZ (1) | NZ589690A (es) |
PL (1) | PL2280952T3 (es) |
PT (1) | PT2280952E (es) |
SI (1) | SI2280952T1 (es) |
UA (1) | UA103617C2 (es) |
WO (1) | WO2009135580A1 (es) |
ZA (1) | ZA201008722B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US20130085169A1 (en) | 2010-04-02 | 2013-04-04 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1) |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
EP2611801B1 (de) * | 2010-09-01 | 2016-05-04 | Bayer Intellectual Property GmbH | Herbizid wirksame ketosultame und diketopyridine |
JP2014507452A (ja) * | 2011-03-07 | 2014-03-27 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | キノリン誘導体 |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
EP2679591A1 (en) | 2012-06-29 | 2014-01-01 | Poxel | Thienopyridone derivatives useful as activators of AMPK |
US9394285B2 (en) | 2013-03-15 | 2016-07-19 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
WO2015103480A1 (en) | 2014-01-02 | 2015-07-09 | Massachusetts Eye & Ear Infirmary | Treating ocular neovascularization |
WO2015114663A1 (en) | 2014-01-30 | 2015-08-06 | Council Of Scientific & Industrial Research | Novel thieno [2,3-d]pyrimidin-4(3h)-one compounds with antimycobacterial properties |
EP3310355B1 (en) | 2015-06-16 | 2020-11-11 | University of Virginia Patent Foundation | Ptp4a3 inhibitor for the treatment of cancer |
KR102614872B1 (ko) | 2015-06-25 | 2023-12-15 | 유니버시티 헬스 네트워크 | Hpk1 억제제 및 이의 사용 방법 |
EP3355876A2 (en) | 2015-09-30 | 2018-08-08 | Instituto de Medicina Molecular | Methods for attenuating parasite virulence |
US11584755B2 (en) | 2017-09-26 | 2023-02-21 | Ideaya Biosciences, Inc. | Dihydrothieno[3,2-b]pyridine compounds |
WO2019106087A1 (en) * | 2017-11-29 | 2019-06-06 | Syddansk Universitet | Ampk inhibitors |
CA3178994A1 (en) | 2020-05-19 | 2021-11-25 | Iyassu Sebhat | Ampk activators |
CN116390925A (zh) | 2020-06-26 | 2023-07-04 | 卡尔优普公司 | Ampk活化剂 |
WO2022072397A1 (en) | 2020-09-30 | 2022-04-07 | Bioverativ Therapeutics Inc. | Ampk activators and methods of use thereof |
WO2022106892A1 (en) | 2020-11-17 | 2022-05-27 | Instituto De Medicina Molecular | Anti-malarial compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8627698D0 (en) * | 1986-11-20 | 1986-12-17 | Boots Co Plc | Therapeutic agents |
DE4444815A1 (de) * | 1994-12-15 | 1996-06-20 | Merck Patent Gmbh | Thienopyridone |
AR040123A1 (es) * | 2002-05-31 | 2005-03-16 | Upjohn Co | Compuestos tiofeno, antihelminticos e insecticidas |
US7119205B2 (en) * | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
WO2006093518A2 (en) * | 2004-06-25 | 2006-09-08 | Apath, Llc | Thienyl compounds for treating virus-related conditions |
US7563813B2 (en) * | 2005-05-13 | 2009-07-21 | Wyeth | Iminothiazolidinone derivatives as SFRP-1 antagonists |
EP1754483A1 (en) | 2005-08-18 | 2007-02-21 | Merck Sante | Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them |
WO2007072094A1 (en) | 2005-12-20 | 2007-06-28 | Richter Gedeon Nyrt. | New compounds |
WO2009124636A1 (en) * | 2008-04-11 | 2009-10-15 | Merck Patent Gmbh | Thienopyridone derivatives as amp-activated protein kinase (ampk) activators |
-
2009
- 2009-04-08 CA CA2723429A patent/CA2723429C/en active Active
- 2009-04-08 CN CN200980116120.5A patent/CN102015676B/zh active Active
- 2009-04-08 SI SI200930319T patent/SI2280952T1/sl unknown
- 2009-04-08 US US12/991,028 patent/US8604202B2/en active Active
- 2009-04-08 PL PL09741799T patent/PL2280952T3/pl unknown
- 2009-04-08 DK DK09741799.2T patent/DK2280952T3/da active
- 2009-04-08 WO PCT/EP2009/002606 patent/WO2009135580A1/en active Application Filing
- 2009-04-08 KR KR1020167007434A patent/KR20160038065A/ko not_active Application Discontinuation
- 2009-04-08 EP EP09741799A patent/EP2280952B1/en active Active
- 2009-04-08 NZ NZ589690A patent/NZ589690A/en unknown
- 2009-04-08 BR BRPI0910832A patent/BRPI0910832B8/pt active IP Right Grant
- 2009-04-08 JP JP2011507805A patent/JP5536757B2/ja active Active
- 2009-04-08 EA EA201001733A patent/EA020773B1/ru not_active IP Right Cessation
- 2009-04-08 PT PT09741799T patent/PT2280952E/pt unknown
- 2009-04-08 MY MYPI2010005160A patent/MY160357A/en unknown
- 2009-04-08 AU AU2009243811A patent/AU2009243811B2/en active Active
- 2009-04-08 KR KR1020107027208A patent/KR101648593B1/ko active IP Right Grant
- 2009-04-08 MX MX2010011916A patent/MX2010011916A/es active IP Right Grant
- 2009-04-08 ES ES09741799T patent/ES2388485T3/es active Active
- 2009-04-08 UA UAA201014384A patent/UA103617C2/ru unknown
- 2009-04-30 AR ARP090101562A patent/AR071530A1/es active IP Right Grant
-
2010
- 2010-10-28 CO CO10134194A patent/CO6331304A2/es active IP Right Grant
- 2010-10-28 IL IL208988A patent/IL208988A/en active IP Right Grant
- 2010-12-02 EC EC2010010654A patent/ECSP10010654A/es unknown
- 2010-12-03 ZA ZA2010/08722A patent/ZA201008722B/en unknown
-
2011
- 2011-10-06 HK HK11110571.3A patent/HK1156313A1/xx unknown
-
2012
- 2012-07-05 HR HRP20120549AT patent/HRP20120549T1/hr unknown
- 2012-09-13 CY CY20121100841T patent/CY1113112T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR071530A1 (es) | Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk) | |
CO2019003349A2 (es) | Compuestos de benzo[b]tiofeno como agonistas de sting | |
AR072148A1 (es) | Derivados de quinoxalindiona | |
AR119698A2 (es) | Compuesto amida n-urea sustituida derivado de aminoácido | |
PE20151501A1 (es) | Inhibidores de prmt5 y sus usos | |
ECSP099056A (es) | Azolilmetiloxiranos, su uso para combatir hongos fitopatógenos, así como productos que los contienen | |
AR086538A1 (es) | COMPUESTOS PARA REDUCIR LA PRODUCCION DE b-AMILOIDE | |
AR092289A1 (es) | Derivados de aminoquinazolina y sus sales y metodos de uso | |
AR078313A1 (es) | Derivados de piridinil-imidazolona inhibidores de quinasas pi3k,composiciones farmaceuticas que los comprenden, metodo para prepararlos y uso de los mismos en el tratamiento de enfermedades autoinmunes e inflamatorias, entre otras | |
AR099379A1 (es) | Compuestos tricíclicos como agentes antineoplásicos | |
AR056986A1 (es) | Aza heterociclos como inhibidores de quinasas. procedimiento de obtencion y composiciones farmaceuticas | |
AR067506A1 (es) | Derivados de quinazolinamida | |
ES2569539T3 (es) | Derivados de piperidin-4-il azetidina como inhibidores de JAK1 | |
CO6331467A2 (es) | Nuevos derivados de imidazo(1,2-a)piridina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
AR080328A1 (es) | Tienopirimidinas que contienen un grupo alquilo sustituido inhibidoras de quinasas mnk1 y/o mnk2, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento de trastornos metabolicos tales como diabetes y obesidad, y trastornos hiperproliferativos, entre otros | |
CO6331463A2 (es) | Nuevos derivados de triazolo(4,3-a)piridina, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
AR061610A1 (es) | Azolilmetiloxiranos, su uso para combatir hongos fitopatogenos, asi como productos que los contienen | |
AR064508A1 (es) | Azolilmetiloxiranos su uso para combatir hongos fitopatogenos asi como productos que contienen los mismos | |
AR075892A1 (es) | Derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
AR082722A1 (es) | Derivados de pirimidina | |
AR054877A1 (es) | Derivados de ciclobutano-3-eno-1,2-diona como inhibidores,reguladores y/o moduladores de quinasas | |
AR051623A1 (es) | Derivados de piridopirimidinona | |
NI201100020A (es) | NUEVOS DERIVADOS DE IMIDAZO[1,2-a] PIRIMIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACIÓN COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACIÓN PARTICULARMENTE COMO INHIBIDOR DE MET. | |
BR112014026266A2 (pt) | derivado de quinazolidinadiona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal | ||
FG | Grant, registration |